3rd Quarter - Report

VAN HEUVELEN STRATEGIES, LLC for GENERIC PHARMACEUTICAL ASSOCIATION

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Consumer Issues/Safety/Products CSP

Prescription drug user fee act and other issues related to generic drugs; Generic Drug User Fee Act, S.3187 Food and Drug Administration Safety and Innovation Act, S.2295 the Patient Safety and Generic Labeling Improvement Act, issues related to patent settlements; H.R.6433, FDA User Fee Corrections Act of 2012.

LobbyistCovered position, as disclosed
DIANE MAJOR Legislative Assistant, Congressman Craig Thomas
ROBERT VAN HEUVELEN Chief of Staff to Senator Kent Conrad

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3187 (112th), S. 2295 (112th), H.R. 6433 (112th)

Health Issues HCR

Prescription drug user fee act and other issues related to generic drugs; Generic Drug User Fee Act, S.3187 Food and Drug Administration Safety and Innovation Act; S.2295 the Patient Safety and Generic Labeling Improvement Act, issues related to patent settlements; H.R.6433, FDA User Fee Corrections Act of 2012.

LobbyistCovered position, as disclosed
DIANE MAJOR Legislative Assistant, Congressman Craig Thomas
ROBERT VAN HEUVELEN Chief of Staff to Senator Kent Conrad

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6433 (112th), S. 2295 (112th), S. 3187 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.